Publication search
with Levodopa-carbidopa intestinal gel (LCIG) as keyword
Moes, Harmen R Buskens, Erik van Laar, Teus
Published in
Parkinsonism & related disorders
The MANAGE-PD tool may help general neurologists in deciding whether a patient with advanced Parkinson's disease should be referred for an advanced therapy. Although the development and clinical validation of MANAGE-PD would appear to serve an important need, we urge the reader to be aware of several methodological concerns. Copyright © 2022 Elsevi...
Antonini, Angelo Odin, Per Schmidt, Peter Cubillos, Fernando Standaert, David G Henriksen, Tove Jimenez-Shahed, Joohi Alobaidi, Ali Jalundhwala, Yash J Bao, Yanjun
...
Published in
Parkinsonism & related disorders
Making Informed Decisions to Aid Timely Management of Parkinson's Disease (MANAGE-PD) is a clinician-reported tool designed to facilitate timely identification and management of patients with advancing Parkinson's disease (PD) with suboptimal symptom control while on standard therapy. The objective of this study was to evaluate the validity and cli...
Mundt-Petersen, Ulrika Odin, Per
Published in
International review of neurobiology
Pump-based Parkinson (PD) therapies, including subcutaneous apomorphine infusion (CSA) and levodopa-carbidopa intestinal gel (LCIG), presently constitute the most effective pharmacological treatments available for advanced PD. These therapies are based on a more constant delivery of the dopaminergic drug resulting in a more continuous dopaminergic ...
